Technology Platform
Nutraceutical Development
BM-A1 Clinical Trial
Therapeutic Development
Publications |
Aging-Intervention Technology and Therapeutic Development
BioMarker's patented technologies enable the discovery and development of therapeutic interventions that mimic the gene and protein expression profiles of animal models of extended lifespan, such as certain dwarf animals, and animals subject to caloric restriction. These mimetics can be developed to treat and/or prevent a broad spectrum of diseases that accompany aging. The technologies are based on identification of genes that control the aging process: gene and protein expression profiling is used to identify interventions that mimic the effects of the model. Such mimetics should slow the rate of aging in mammals, rapidly reprogramming genes to a more youthful state, and provide potent beneficial health effects – cancer preventive properties, improved immune function, cardiovascular health, improved insulin sensitivity and glucose disposal.
BioMarker's Proprietary Discovery System
Much of our work focuses upon calorie restriction (CR), the single most scientifically validated model for life span extension. >>more |